|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM311773540 |
| 003 |
DE-627 |
| 005 |
20231225142956.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2020.108518
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1039.xml
|
| 035 |
|
|
|a (DE-627)NLM311773540
|
| 035 |
|
|
|a (NLM)32599278
|
| 035 |
|
|
|a (PII)S1521-6616(20)30562-3
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Morales-Ortega, Alejandro
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Imatinib for COVID-19
|b A case report
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 25.08.2020
|
| 500 |
|
|
|a Date Revised 10.01.2021
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Case Reports
|
| 650 |
|
4 |
|a Letter
|
| 650 |
|
4 |
|a ABL kinase inhibitor
|
| 650 |
|
4 |
|a COVID-19
|
| 650 |
|
4 |
|a Imatinib
|
| 650 |
|
4 |
|a SARS-CoV-2
|
| 650 |
|
4 |
|a Treatment
|
| 650 |
|
7 |
|a Biomarkers
|2 NLM
|
| 650 |
|
7 |
|a Drug Combinations
|2 NLM
|
| 650 |
|
7 |
|a Protein Kinase Inhibitors
|2 NLM
|
| 650 |
|
7 |
|a lopinavir-ritonavir drug combination
|2 NLM
|
| 650 |
|
7 |
|a Lopinavir
|2 NLM
|
| 650 |
|
7 |
|a 2494G1JF75
|2 NLM
|
| 650 |
|
7 |
|a Hydroxychloroquine
|2 NLM
|
| 650 |
|
7 |
|a 4QWG6N8QKH
|2 NLM
|
| 650 |
|
7 |
|a Imatinib Mesylate
|2 NLM
|
| 650 |
|
7 |
|a 8A1O1M485B
|2 NLM
|
| 650 |
|
7 |
|a C-Reactive Protein
|2 NLM
|
| 650 |
|
7 |
|a 9007-41-4
|2 NLM
|
| 650 |
|
7 |
|a Ritonavir
|2 NLM
|
| 650 |
|
7 |
|a O3J8G9O825
|2 NLM
|
| 700 |
1 |
|
|a Bernal-Bello, David
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Llarena-Barroso, Cristina
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Frutos-Pérez, Begoña
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Duarte-Millán, Miguel Ángel
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a García de Viedma-García, Vanessa
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Farfán-Sedano, Ana Isabel
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Canalejo-Castrillero, Eduardo
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ruiz-Giardín, José Manuel
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ruiz-Ruiz, Justo
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a San Martín-López, Juan Víctor
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 218(2020) vom: 15. Sept., Seite 108518
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:218
|g year:2020
|g day:15
|g month:09
|g pages:108518
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2020.108518
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 218
|j 2020
|b 15
|c 09
|h 108518
|